Skip to content

ODEPHARMA

Active
Public limited companyfounded 1990active for 36 yearsLeopold II Laan(Odk) 168, 8670 Koksijde, BelgiumKBO/BCE: BE 0441.639.812
Summary

ODEPHARMA has been active since 1990 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €115,621 and a net result of €69,636. Equity is growing by about 61% per year across the filed financial years. Its solvency ranks better than 59% of 12,661 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Directors

Directors
1 director, last change in 2024

Board 1

Lindammer
Director (not named in the articles) · since 01-10-2024 · Limited partnership · permanent representative: Marceau DECRU
Current

Permanent representatives 1

Marceau DECRU
Permanent representative · since 01-10-2024 · for Lindammer
Current
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ. See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
3 of this company's 6 Belgian Official Gazette deeds have not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.

Mandate history

4 people since 2023, 1 in office
Show
  • Board
  • Day-to-day management
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
Lindammer
  • Director (not named in the articles), from 01-10-2024 to date
An LOUWAGIE
  • Director, from before 23-02-2023 to 01-10-2024
Kristiaan TRYPSTEEN
  • Director, from before 23-02-2023 to 01-10-2024
  • Managing director, from before 23-02-2023 to 01-10-2024
PAN PROJECT
  • Director, from before 23-02-2023 to 01-10-2024
See the board, name and registered office on a given date →

Owners and capital

Owners

1 owner

Chain of control

  1. PAN PROJECT 99.52%
  2. ODEPHARMA

Highest known parent: PAN PROJECT. The sources do not say who stands above it.

Sources: the companies' annual accounts, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.

Capital and shareholders

Capital over the years
  1. 27-12-2024 Capital stated in the deed · €62,000 · 1,250 shares